You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FTY720

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,

Active, not recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +3 more
  • Rochester, Minnesota
  • +1 more
Jan 17, 2023

Breast Carcinoma Trial in Rochester, Columbus, Richmond (Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration)

Active, not recruiting
  • Breast Carcinoma
  • Rochester, Minnesota
  • +2 more
Jul 6, 2022

Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)

Enrolling by invitation
  • Interstitial Fibrosis
  • +6 more
  • Houston, Texas
    Houston Methodist Research Institute
Jan 23, 2023

Renal Insufficiency Trial in Moscow (fingolimod (FTY720))

Completed
  • Renal Insufficiency
  • fingolimod (FTY720)
  • Moscow, Russian Federation
    Novartis Investigator Site
Dec 6, 2020

Relapsing Multiple Sclerosis (RMS) Trial in China (Fingolimod 0.5mg)

Recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Fingolimod 0.5mg
  • Beijing, Beijing, China
  • +12 more
Feb 3, 2022

Multiple Sclerosis Trial in Belgium, Germany, Italy (Fingolimod)

Completed
Has Results
  • Multiple Sclerosis
  • Gent, Belgium
  • +3 more
Jan 21, 2021

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Relapsing Remitting Multiple Sclerosis RRMS Trial in Germany, Switzerland (Fingolimod)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis RRMS
  • Bochum, Germany
  • +9 more
Feb 14, 2020

Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of

Recruiting
  • Intracerebral Hemorrhage
  • +4 more
  • Fingolimod 0.5 mg
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Nov 28, 2022

Stroke, Vascular Accident, Cerebral Stroke Trial in Tianjin (Fingolimod)

Completed
  • Stroke
  • +4 more
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 15, 2018

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Rett's Syndrome Trial in Basel (fingolimod (FTY720))

Completed
  • Rett's Syndrome
  • fingolimod (FTY720)
  • Basel, Switzerland
    Department of Neuropediatrics - University Children's Hospital
Jun 14, 2018

Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid, Lupus Erythematosus, Systemic Trial in West Hollywood

Completed
  • Lupus Erythematosus, Cutaneous
  • +4 more
  • West Hollywood, California
    Cedars Sinai Medical Center-Wallace Rheumatic Study Center
Aug 12, 2021

Vulvodynia: Identification of Potential Relevant Biomarkers

Completed
  • Vulvodynia
    • Saint Louis, Missouri
    • +1 more
    Aug 26, 2020

    Birth Defects in Neonatal Intensive Care Units

    Recruiting
    • Genetic Disease
    • +2 more
      • Shanghai, Shanghai, China
        Children Hospital of Fudan University
      Mar 7, 2022

      Acute Ischemic Stroke, Reperfusion, Large Vessel Occlusion Trial in Liuzhou, Changsha, Pingxiang (Y-6 sublingual tablets,

      Not yet recruiting
      • Acute Ischemic Stroke
      • +2 more
      • Y-6 sublingual tablets
      • Placebo tablets of Y-6 sublingual tablet
      • Liuzhou, Guangxi, China
      • +2 more
      Apr 19, 2023

      Relapsing-remitting Multiple Sclerosis Trial in Germany (fingolimod)

      Completed
      Has Results
      • Relapsing-remitting Multiple Sclerosis
      • Ostfildern, Baden-Wuerttemberg, Germany
      • +25 more
      Sep 6, 2018

      Intracerebral Hemorrhage Trial (Fingolimod)

      Not yet recruiting
      • Intracerebral Hemorrhage
      • (no location specified)
      Oct 17, 2023

      Multiple Sclerosis (MS) Trial in Dallas (Alemtuzumab)

      Completed
      Has Results
      • Multiple Sclerosis (MS)
      • Dallas, Texas
      • +1 more
      Jan 24, 2022

      Relapsing Forms of Multiple Sclerosis Trial in Worldwide (Fingolimod)

      Completed
      Has Results
      • Relapsing Forms of Multiple Sclerosis
      • Cullman, Alabama
      • +457 more
      Mar 26, 2021

      Renal Transplantation Trial (FTY720)

      Completed
      • Renal Transplantation
      • FTY720
      • (no location specified)
      Aug 18, 2017

      Relapsing Remitting Multiple Sclerosis Trial in Mecidiyekoy, Uskudar, Istanbul (Fingolimod 0.5 mg)

      Completed
      Has Results
      • Relapsing Remitting Multiple Sclerosis
      • Fingolimod 0.5 mg
      • Mecidiyekoy, Istanbul, Turkey
      • +2 more
      Sep 3, 2019

      Relapsing Remitting Multiple Sclerosis Trial in Australia, Spain (Fingolimod (FTY720))

      Completed
      Has Results
      • Relapsing Remitting Multiple Sclerosis
      • Fingolimod (FTY720)
      • East Gosford, New South Wales, Australia
      • +46 more
      Aug 15, 2018

      Relapsing-remitting Multiple Sclerosis (RRMS) Trial in Worldwide (fingolimod, glatiramer acetate)

      Terminated
      Has Results
      • Relapsing-remitting Multiple Sclerosis (RRMS)
      • Cullman, Alabama
      • +129 more
      Apr 29, 2019

      Kidney Transplantation Trial (FTY720)

      Completed
      • Kidney Transplantation
      • FTY720
      • (no location specified)
      Jun 5, 2017